Ipamorelin 8mg

A 29-amino acid synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH), engineered without the Drug Affinity Complex modification. Designed for short-duration receptor binding studies, allowing researchers to examine acute somatotropic signalling without extended plasma persistence.

A stabilised synthetic analog of Growth Hormone-Releasing Factor (GRF), supplied at 5mg as a higher-yield laboratory format. Suited to extended research programmes or multi-arm experimental designs requiring consistent, larger-volume supply of this well-characterised GHRH analog.

A synthetic small-molecule agonist of the Estrogen-Related Receptor (ERR) nuclear receptor family. A newer research tool compound generating significant interest in metabolic biology and mitochondrial research for its ability to activate ERR-mediated transcriptional programmes in controlled experimental models.

A synthetic decapeptide fragment of the endogenous kisspeptin family, retaining the C-terminal sequence required for receptor activation. Designed to mirror native KISS1R binding activity, and well-characterised as a reference compound in research examining hypothalamic-pituitary-gonadal axis signalling interactions and reproductive endocrine dynamics.